3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
12
Gastrointestinal
3
CNS
2
Other solid neoplasm
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Squamous Cell Carcinoma of Head and Neck
389
Head and Neck Neoplasms
340
Carcinoma, Non-Small-Cell Lung
230
Melanoma
155
Colorectal Neoplasms
152
Breast Neoplasms
138
Ovarian Neoplasms
125
Neoplasms
103
Stomach Neoplasms
101
Carcinoma, Renal Cell
101
Neoplasm Metastasis
94
Pancreatic Neoplasms
93
Lung Neoplasms
87
Uterine Cervical Neoplasms
81
Triple Negative Breast Neoplasms
75
Esophageal Neoplasms
75
Prostatic Neoplasms
70
Urinary Bladder Neoplasms
69
Thyroid Neoplasms
62
Carcinoma, Squamous Cell
57
Carcinoma, Hepatocellular
57
Sarcoma
54
Endometrial Neoplasms
54
Carcinoma, Transitional Cell
54
Small Cell Lung Carcinoma
50
Salivary Gland Neoplasms
49
Colonic Neoplasms
41
Nasopharyngeal Carcinoma
38
Mouth Neoplasms
37
Kidney Neoplasms
34
Interventions
pembrolizumab
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Chordoma
×
Head & Neck
×
Clear all
NCT04670679
2026-03-25
FLAGSHP-1
Erasca, Inc.
Phase 1
Active not recruiting
90 enrolled